Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-02-04 @ 1:07 AM
Study NCT ID:
NCT01649466
Status:
COMPLETED
Last Update Posted:
2016-11-17
First Post:
2012-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
Sponsor:
Novartis Pharmaceuticals
Organization: